@ABFredriksen Profile picture

Agnete B. Fredriksen

@ABFredriksen

Co-founder, Chief Innovation and Strategy Officer at Vaccibody AS.

Similar User
Oslo Cancer Cluster photo

@OsloCancer

RADFORSK photo

@radforsk

Jónas Einarsson photo

@JEinarsson

The Lab of Adaptive Immunity and Homeostasis photo

@AndersenJT

Kjetil Tasken photo

@KjetilTasken

Pål Kristian Selbo photo

@pkselbo

Bjørn Fuglaas photo

@bfuglaas

Forskningsparken - Oslo Science Park photo

@OsloSciencePark

Photocure photo

@PhotocureASA

Joining forces with >60 leaders in immunology to encourage FDA to increase the focus on T cell responses in COVID-19 and infectious diseases in general.

Here is the full text of the letter to the FDA about T cell responses in COVID vaccine studies.



We select our partners carefully! Enjoy the collaboration with the competent team at Adaptive Biotechnologies generating 3rd generations vaccines. Listen to the webcast at 4 pm today. bit.ly/36uEsEl


This is an amazing achievement by the entire Vaccibody family! Thanks to the patients, investigators, collaborators and all Vaccibody team members for the dedication to this important study. vaccibody.com/wp-content/upl…


Proud and excited for reaching this milestone! Rewarding to work with JZ and the rest of the Nektar team.

We are excited to announce we reached an important milestone in our partnership with Vaccibody, dosing the first patient in our Phase 1/2a study arm evaluating the combination of bempeg with VB10.NEO. Read more: bit.ly/3afAVei

Tweet Image 1


Very excited about the strong signs of vaccine-induces clinical responses, backed up with a range of scientificly sound correlations, in our cancer neoantigen vaccine trial! lnkd.in/eP4csKp #cancerresearch #cancervaccine #neoantigens


New times in Vaccibody! Thx to Martin for 4 great years! And a warm welcome to Michael! Ready for next phase💪🏼 vaccibody.com/organizational…


Thanks for the invite and opportunity to share my journey. Really enjoyed the entire program and the interactive discussions!

Last fireside chat before our Panel! Wonderful to have @Vaccibody President & CSO Agnete Fredriksen sharing with us - “How to manage the #science of a #biotech company”!

Tweet Image 1
Tweet Image 2
Tweet Image 3


Agnete B. Fredriksen Reposted

🎤 Speaker #1 - We're thrilled to have Agnete Fredriksen @ABFredriksen, CSO of @Vaccibody, join us at Labiotech Insider Day! Take a sneak peek at the program & register today! 👉🏻 bit.ly/2KHPWLe 👈🏻 #biotech #LBRefresh

Tweet Image 1

In San Francisco speaking at the Mol Med Tri-Con while TV2 tells about our Roche collaboration. Exciting days. tv2.no/nyheter/104662…


Agnete B. Fredriksen Reposted

NRK EKKO har laget et flott radioinnslag om vår porteføljebedrift Vaccibody der @ABFredriksen forteller om hvordan de utvikler persontilpassede kreftvaksiner: radio.nrk.no/serie/ekko#t=5… #helsenæring #kreft

Tweet Image 1

Finansavisen lørdag- hvorfor er Vaccibody og Nektar så gode partnere?

Tweet Image 1

Agnete B. Fredriksen Reposted

We’ve entered into a new clinical collaboration with Vaccibody to combine their personalized neo-antigen cancer vaccine with NKTR-214. Learn more about this combination's design to harness specific T cell clonal expansion in the fight against cancer: bit.ly/2xqtkr6

Tweet Image 1

Trying to convince our Minister of Trade and Industry to create better incentiver for startup and founders:-) #timeforchange #startup #politicians

Tweet Image 1

Agnete B. Fredriksen Reposted

In our latest newsletter you get an insight into the Norwegian Health Industry. Plus you get to know Vaccibody's cancer vaccine technology and a chance to visit a SPARK Norway meeting.- mailchi.mp/884a00db91c7/a…

Tweet Image 1

Agnete B. Fredriksen Reposted

Ny pod er ute nå. @elikirand har besøk av @ABFredriksen og Martin Bonde fra vår porteføljebedrift #Vaccibody: Vi snakker om utviklingen av deres persontilpassede kreftvaksine og planer for framtiden soundcloud.com/user-972208711…

Tweet Image 1

Agnete B. Fredriksen Reposted

– Vi skreddersyr kreftvaksiner til hver pasient. Vi tar immunterapi ett skritt videre, og bruker kunnskapen til å utvikle enda mer persontilpasset medisin, sier president og grunnlegger av #Vaccibody, @ABFredriksen, til VG. vg.no/i/6nKj0L


Loading...

Something went wrong.


Something went wrong.